New Data Released At ISHLT Meeting May Impact Treatment for Patients With …MarketWatch (press release)While there is no known cure for PAH, treatment options include medications, oxygen therapy, and depending on severity of the disease, lung transpla…
XDx Announces Positive Results from European CARGO II Study of AlloMap … – PharmiWeb.com (press release)
XDx Announces Positive Results from European CARGO II Study of AlloMap …PharmiWeb.com (press release)AlloMap is XDx's FDA-cleared and CE-marked, easy and convenient, non-invasive blood test that aids physicians in determining a stable heart trans…
Common skin diseases not getting proper treatment – China Daily
Common skin diseases not getting proper treatmentChina DailyAnother survey of patients with dermatitis, eczema or hives, showed that 44 percent used corticosteroids therapy inappropriately, and only one in four had a satisfactory outcome. “Patients s…
Skater promotes organ donation – Windsor Star
stv.tvSkater promotes organ donationWindsor Star"It is easy to sign up to become an organ donor. A lot of people don't realize that you can do it online now," Ricci said. Members of the public are welcome to attend the event, but are enco…
Ready. Set. March for Babies! – MarketWatch (press release)
Ready. Set. March for Babies!MarketWatch (press release)After receiving care at Hillcrest Hospital, doctors were able to slow her contractions with corticosteroids. She delivered both her son and daughter four weeks early. Today, Brooks is a vibrant fi…
Heart transplant recipient raises awareness on organ and tissue donations
Ask Sherrie Francey, 53, why she supports organ and tissue donation, and she has a simple answer: She's got a heart. Literally.
Early intervention of biologic therapies improves outcome for Crohn's disease – News-Medical.net
Early intervention of biologic therapies improves outcome for Crohn's diseaseNews-Medical.netThere is no known cure for Crohn's disease, and traditional treatment is focused on a "step-up" strategy of managing inflammatory symptoms, s…
Drug interactions won't exclude HCV transplant or HIV co-infected patients … – Medical Xpress
Drug interactions won't exclude HCV transplant or HIV co-infected patients …Medical XpressIn the first multicentric study of the efficacy and safety of the protease inhibitors (PI) Boceprevir or Telaprevir in patients with severe HCV genotype 1 (…
XDx Announces Positive Results from European CARGO II Study of AlloMap(R … – MarketWatch (press release)
XDx Announces Positive Results from European CARGO II Study of AlloMap(R …MarketWatch (press release)AlloMap is XDx's FDA-cleared and CE-marked, easy and convenient, non-invasive blood test that aids physicians in determining a stable heart trans…
XDx Announces Positive Results from European CARGO II Study of AlloMap® Molecular Expression Testing
XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor immune status in transplant recipients and autoimmune diseases, today announced positive …